BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 27830268)

  • 21. Chlorophyllin significantly reduces benzo[a]pyrene-DNA adduct formation and alters cytochrome P450 1A1 and 1B1 expression and EROD activity in normal human mammary epithelial cells.
    Keshava C; Divi RL; Einem TL; Richardson DL; Leonard SL; Keshava N; Poirier MC; Weston A
    Environ Mol Mutagen; 2009 Mar; 50(2):134-44. PubMed ID: 19152381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Competing roles of cytochrome P450 1A1/1B1 and aldo-keto reductase 1A1 in the metabolic activation of (+/-)-7,8-dihydroxy-7,8-dihydro-benzo[a]pyrene in human bronchoalveolar cell extracts.
    Jiang H; Shen YM; Quinn AM; Penning TM
    Chem Res Toxicol; 2005 Feb; 18(2):365-74. PubMed ID: 15720144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppressive effect of 1-nitropyrene on benzo[a]pyrene-induced CYP1A1 protein expression in HepG2 cells.
    Cherng SH; Hsu SL; Yang JL; Yu CT; Lee H
    Toxicol Lett; 2006 Mar; 161(3):236-43. PubMed ID: 16280210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circadian Regulation of Benzo[a]Pyrene Metabolism and DNA Adduct Formation in Breast Cells and the Mouse Mammary Gland.
    Schmitt EE; Barhoumi R; Metz RP; Porter WW
    Mol Pharmacol; 2017 Mar; 91(3):178-188. PubMed ID: 28007926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation between CYP1A1 transcript, protein level, enzyme activity and DNA adduct formation in normal human mammary epithelial cell strains exposed to benzo[a]pyrene.
    Divi RL; Lindeman TL; Shockley ME; Keshava C; Weston A; Poirier MC
    Mutagenesis; 2014 Nov; 29(6):409-17. PubMed ID: 25245543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polycyclic aromatic hydrocarbon-inducible DNA adducts: evidence by 32P-postlabeling and use of knockout mice for Ah receptor-independent mechanisms of metabolic activation in vivo.
    Kondraganti SR; Fernandez-Salguero P; Gonzalez FJ; Ramos KS; Jiang W; Moorthy B
    Int J Cancer; 2003 Jan; 103(1):5-11. PubMed ID: 12455047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benzo[a]pyrene and tumor necrosis factor-α coordinately increase genotoxic damage and the production of proinflammatory mediators in alveolar epithelial type II cells.
    Umannová L; Machala M; Topinka J; Schmuczerová J; Krčmář P; Neča J; Šujanová K; Kozubík A; Vondráček J
    Toxicol Lett; 2011 Oct; 206(2):121-9. PubMed ID: 21745554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 5,7-Dimethoxyflavone downregulates CYP1A1 expression and benzo[a]pyrene-induced DNA binding in Hep G2 cells.
    Wen X; Walle UK; Walle T
    Carcinogenesis; 2005 Apr; 26(4):803-9. PubMed ID: 15661813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Benzo[g,h,i]perylene synergistically transactivates benzo[a]pyrene-induced CYP1A1 gene expression by aryl hydrocarbon receptor pathway.
    Cherng SH; Lin P; Yang JL; Hsu SL; Lee H
    Toxicol Appl Pharmacol; 2001 Jan; 170(1):63-8. PubMed ID: 11141357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytochrome P450 1A1 (CYP1A1) protects against nonalcoholic fatty liver disease caused by Western diet containing benzo[a]pyrene in mice.
    Uno S; Nebert DW; Makishima M
    Food Chem Toxicol; 2018 Mar; 113():73-82. PubMed ID: 29366871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resveratrol, a natural aryl hydrocarbon receptor antagonist, protects lung from DNA damage and apoptosis caused by benzo[a]pyrene.
    Revel A; Raanani H; Younglai E; Xu J; Rogers I; Han R; Savouret JF; Casper RF
    J Appl Toxicol; 2003; 23(4):255-61. PubMed ID: 12884409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytochrome b5 and epoxide hydrolase contribute to benzo[a]pyrene-DNA adduct formation catalyzed by cytochrome P450 1A1 under low NADPH:P450 oxidoreductase conditions.
    Stiborová M; Moserová M; Černá V; Indra R; Dračínský M; Šulc M; Henderson CJ; Wolf CR; Schmeiser HH; Phillips DH; Frei E; Arlt VM
    Toxicology; 2014 Apr; 318():1-12. PubMed ID: 24530354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitamin D receptor activation enhances benzo[a]pyrene metabolism via CYP1A1 expression in macrophages.
    Matsunawa M; Akagi D; Uno S; Endo-Umeda K; Yamada S; Ikeda K; Makishima M
    Drug Metab Dispos; 2012 Nov; 40(11):2059-66. PubMed ID: 22837390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of CYP1A1, CYP1A2, and CYP1B1 mRNAs by nitropolycyclic aromatic hydrocarbons in various human tissue-derived cells: chemical-, cytochrome P450 isoform-, and cell-specific differences.
    Iwanari M; Nakajima M; Kizu R; Hayakawa K; Yokoi T
    Arch Toxicol; 2002 Jun; 76(5-6):287-98. PubMed ID: 12107646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo and in vitro inhibition of CYP1A-dependent activity in Fundulus heteroclitus by the polynuclear aromatic hydrocarbon fluoranthene.
    Willett KL; Wassenberg D; Lienesch L; Reichert W; Di Giulio RT
    Toxicol Appl Pharmacol; 2001 Dec; 177(3):264-71. PubMed ID: 11749126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA adduct formation in precision-cut rat liver and lung slices exposed to benzo[a]pyrene.
    Harrigan JA; Vezina CM; McGarrigle BP; Ersing N; Box HC; Maccubbin AE; Olson JR
    Toxicol Sci; 2004 Feb; 77(2):307-14. PubMed ID: 14691214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral exposure to benzo[a]pyrene in the mouse: detoxication by inducible cytochrome P450 is more important than metabolic activation.
    Uno S; Dalton TP; Derkenne S; Curran CP; Miller ML; Shertzer HG; Nebert DW
    Mol Pharmacol; 2004 May; 65(5):1225-37. PubMed ID: 15102951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytochrome P450 1A1 expression and activity in Caco-2 cells: modulation by apple juice extract and certain apple polyphenols.
    Pohl C; Will F; Dietrich H; Schrenk D
    J Agric Food Chem; 2006 Dec; 54(26):10262-8. PubMed ID: 17177569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral benzo[a]pyrene in Cyp1 knockout mouse lines: CYP1A1 important in detoxication, CYP1B1 metabolism required for immune damage independent of total-body burden and clearance rate.
    Uno S; Dalton TP; Dragin N; Curran CP; Derkenne S; Miller ML; Shertzer HG; Gonzalez FJ; Nebert DW
    Mol Pharmacol; 2006 Apr; 69(4):1103-14. PubMed ID: 16377763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of benzo[a]pyrene-activating enzymes and DNA binding in human bronchial epithelial BEAS-2B cells by methoxylated flavonoids.
    Tsuji PA; Walle T
    Carcinogenesis; 2006 Aug; 27(8):1579-85. PubMed ID: 16484233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.